CareFusion Corp. (CFN: Quote) issued an update regarding its previously announced voluntary recall of EnVe ventilators. The FDA has classified this action as a Class 1 recall.
The company said that the device will activate both audible and visual alarms to notify the health care professional that ventilation delivery to the patient may be compromised. A Class I recall is defined as having a reasonable probability of serious adverse health consequences or death associated with use of the defective units.
Remediation plans previously announced by the company are underway and will be completed at customers' sites. To date, there have been no reports of patient harm associated with the affected devices, CareFusion said.
The company initiated the voluntary recall in June. The products subject to the recall were manufactured between December 2010 and January 2012. The company noted that the action has no effect on the manufacture or distribution of current products.
In June, CareFusion sent an urgent Recall Notification to customers stating that the company had identified potential risks associated with the EnVe ventilator. A leak may occur in the patient breathing circuit or the system, resulting in the ventilator not holding the set Positive End Expiratory Pressure or PEEP value either intermittently or continuously, the company said.
by RTT Staff Writer
For comments and feedback: firstname.lastname@example.org